WBB Securities Upgrades Turn Therapeutics to Hold, Maintains Price Target to $10
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsUpgradesPrice Target
WBB Securities analyst Karen Sterling upgrades Turn Therapeutics (NASDAQ:TTRX) from Sell to Hold and maintains the price target from $10 to $10.
WBB Securities analyst Karen Sterling upgrades Turn Therapeutics (NASDAQ:TTRX) from Sell to Hold and maintains the price target from $10 to $10.